NEW YORK, June 10, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX:OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced American Oncology Network, Inc. (AON) (OTCQX:AONC), a rapidly-growing network of community-based oncology practices, has qualified to trade on the OTCQX® Best Market. American Oncology Network, Inc. previously traded on NASDAQ. American Oncology Network, Inc. begins trading today on OTCQX under the symbol "AONC." U.S. investors c ...

Company Overview - American Oncology Network, Inc. (AON) has qualified to trade on the OTCQX® Best Market, transitioning from NASDAQ to OTCQX under the symbol "AONC" [1] - AON is a rapidly-growing network of community-based oncology practices, founded in 2018, representing over 240 providers across 21 states [4] - The company focuses on innovative healthcare solutions through a physician-led model, promoting value-based care to improve patient outcomes while reducing costs [4] Financial Performance - AON has achieved a five-year revenue compound annual growth rate (CAGR) of 42% and has added more than 40 providers and four new practices in the current year [3] - The company emphasizes its robust financial position and the momentum it continues to experience in the oncology sector [3] Market Context - Trading on the OTCQX Market provides companies with efficient and cost-effective access to U.S. capital markets, with streamlined requirements designed to lower costs and complexity [2] - Companies must meet high financial standards and demonstrate compliance with applicable securities laws to qualify for OTCQX [2] Strategic Goals - AON is committed to promoting health equity by addressing disparities in cancer care and ensuring access to quality care for all patients [4] - The company aims to create long-term value through advanced patient treatment options, clinical research, and comprehensive care nationwide [3]

FORT MYERS, Fla., June 06, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's largest and fastest-growing networks of community oncology practices, announced the expansion of its radiation oncology services with the opening of Low Country Radiation in Waycross, Georgia.  The clinic can deliver external beam radiation therapy (EBRT), an effective treatment for various cancers. Radiation therapy uses high doses of radiation to kill or slow the growth of cancer cells. W ...

Core Insights - American Oncology Network (AON) has appointed David Afshar as the chief financial and operating officer, bringing over 25 years of experience in healthcare services and private equity-backed environments [1][2][4] - AON aims to close the cancer care gap and ensure accessibility and affordability of cancer care in communities, emphasizing the importance of independent medical practices [2][4] - AON's network includes more than 240 providers across 21 states, focusing on innovative healthcare solutions and value-based care to improve patient outcomes while reducing costs [4] Company Overview - AON was founded in 2018 and has rapidly expanded its network, representing a significant number of healthcare providers [4] - The organization is committed to promoting health equity by addressing disparities in cancer care and ensuring all patients have access to necessary care [4] - AON provides comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise to its network physicians [4] Leadership Background - David Afshar has held CFO positions at U.S. Heart and Vascular, Aveanna Healthcare, and ApolloMD, and has experience in M&A, integrations, and capital markets [1][2] - Afshar was recognized in 2023 as one of the "Top 25 CFOs of Georgia" by Finance & Investing magazine, highlighting his achievements in the field [2][3]

FORT MYERS, Fla., May 21, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (NASDAQ:AONC), a rapidly growing network of community-based oncology practices, announced today its decision to voluntarily delist its Class A common stock and warrants from The Nasdaq Capital Market ("Nasdaq"). The Company's decision to delist its securities from Nasdaq was recommended to the Board of Directors (the "Board") of the Company by a Special Committee (the "Special Committee") of the Board compr ...

FORT MYERS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (NASDAQ:AONC), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of William "Bill" J. Valle to its Board of Directors, effective April 19, 2024. "On behalf of the Board, I am honored to be officially welcoming Bill," said Stephen "Fred" Divers, MD, AON's chief medical officer and vice chairman of the Board. "Bill has extensive experience and knowledge that wil ...

Core Insights - American Oncology Network (AON) has appointed William "Bill" J. Valle to its Board of Directors, effective April 19, 2024, to enhance its mission in cancer care [1][2] - Valle brings extensive experience from his 14-year tenure at Fresenius Medical Care AG Management and other healthcare organizations, which will contribute to AON's growth and innovation [1][2] - AON is committed to improving access to cancer care and addressing disparities in cancer treatment, with a network of over 240 providers across 21 states [3] Company Overview - AON is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology and other specialties, founded in 2018 [3] - The organization promotes value-based care, aiming to improve patient outcomes while reducing costs and expanding access to quality care [3] - AON provides its network physicians with essential tools and support, enabling them to focus on delivering high standards of care [3]

American Oncology Network, Inc. (NASDAQ:AONC) Q1 2024 Earnings Conference Call May 16, 2024 8:30 AM ET Company Participants David Gould - Chief Financial Officer Todd Schonherz - Chief Executive Officer Conference Call Participants Operator Good morning and welcome to the American Oncology Network's First Quarter 2024 Earnings Conference Call. Today's call is being recorded and we have allocated one hour for prepared remarks and Q&A. At this time I'd like to turn the conference over to David Gould, Chief Fi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04321 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorporat ...

Exhibit 99.1 American Oncology Network, Inc. Announces First Quarter 2024 Financial Results First Quarter 2024 Highlights • Revenue of $364.3 million increased by 20.0% compared to the prior year quarter o Patient encounter growth of 7.1% as compared to the prior year quarter • Added 17 new providers to the AON platform o Expanded in Texas and Maryland markets FORT MYERS, Fla., May 15, 2024 – American Oncology Network, Inc. (NASDAQ: AONC), a leading oncology platform with an innovative model of physician-le ...